Cardiomyopathy associated with clozapine

Experimental and Clinical Psychopharmacology
Sungwon RohYang Suk Kim

Abstract

Clozapine is an atypical antipsychotic agent that is more effective than the standard neuroleptics currently used for treating refractory schizophrenia. In addition, clozapine is a drug with few extrapyramidal side effects. However, clozapine is also associated with potentially serious adverse effects, such as cardiac complications as well as agranulocytosis. Clozapine-related cardiomyopathy has not been previously reported in East Asia. This report describes a 31-year-old Korean male patient with schizophrenia who developed dilated cardiomyopathy on treatment with clozapine. The removal of clozapine caused subsequent physical improvement. However, the readministration of clozapine for managing relapse of psychosis caused a recurrence of dilated cardiomyopathy in this patient. Therefore, this is the 1st report showing that the 2nd trial of clozapine caused recurrence of cardiomyopathy associated with clozapine. Thus, this report adds important support for a causal relation between clozapine and cardiac complications. In conclusion, this report attempts to raise awareness of clozapine-related cardiomyopathy.

References

Nov 1, 1995·Schizophrenia Research·B BandelowE Rüther
Dec 10, 1999·Lancet·J G KilianD S Celermajer
Oct 19, 2000·The Australian and New Zealand Journal of Psychiatry·D DegnerE Rüther
May 19, 2001·BMJ : British Medical Journal·D M CoulterI R Edwards
Jul 21, 2001·The New England Journal of Medicine·L La GrenadeA Trontell
Jul 31, 2001·Journal of Clinical Psychopharmacology·S HäggT G Soderström
Mar 13, 2003·British Journal of Clinical Pharmacology·K S VaddadiG Vaddadi
Jun 5, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Toshiyuki SomeyaSaburo Takahashi
Jan 22, 2005·Journal of Clinical Pharmacy and Therapeutics·P M WehmeierH Remschmidt
Apr 15, 2005·Medical Reference Services Quarterly·Marie K Saimbert

❮ Previous
Next ❯

Citations

Jan 1, 2009·BMJ Case Reports·Anil K TanejaJohn Bayliss
Aug 19, 2014·International Journal of Cardiology·Mohammed AlawamiChristopher Kenedi
Aug 23, 2016·Case Reports in Cardiology·Josef Finsterer, Claudia Stöllberger
Jul 6, 2007·Expert Review of Neurotherapeutics·James W Michelsen, Jonathan M Meyer
Jul 16, 2008·The Australian and New Zealand Journal of Psychiatry·Hadi Hussain, Mujeeb Abid Butt
May 30, 2017·BMJ Case Reports·Mariëtte NederlofEibert Roelof Heerdink
Jun 1, 2010·International Journal of Psychiatry in Clinical Practice·Chaveewan RatanajamitWantana Reanmongkol
Jul 5, 2011·Expert Review of Neurotherapeutics·Maurizio PompiliPaolo Girardi
May 26, 2016·Current Psychiatry Reports·Martina CurtoRoss J Baldessarini
Dec 31, 2020·International Journal of Molecular Sciences·Joyce BernardiAdemuyiwa S Aromolaran
Sep 2, 2021·Irish Journal of Psychological Medicine·F WilliamsA Rowe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.